ANNA DELEON: Open Payments
NPI 1538797675 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 10 payments from 8 companies in 2025. Trend: 2023 $216 · 2024 $84 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
Products named: CAPLYTA, INGREZZA, AUSTEDO XR, Auvelity, ARISTADA, SPRAVATO, REXULTI, VRAYLAR.
Industry payments across MS — which companies pay providers there.
